Abstract
The novel coronavirus (COVID-19) emerged in Wuhan, China, in December 2019. To evaluate the knowledge of intensive care physicians in Turkey about COVID-19 and their attitudes towards the strategies and application methods to be used for COVID-19 cases that need to be followed up in an intensive care unit, and to raise awareness about this issue. The population for this descriptive study comprised clinicians working in a variety of healthcare organizations in Turkey who provide monitoring and treatment within the intensive care process for COVID-19 patients. Data were collected online using a survey form on the SurveyMonkey website between April 20 and April 25, 2020. The mean age of the 248 intensive care clinicians participating in the study was 37.2 ± 13.7 years and 49.19% were female. High rates of classical laryngoscope use were observed, especially among clinicians employed in state hospitals. Among all the participants, 54.8% stated that they were undecided about corticosteroid treatment for patients who had been intubated due to COVID-19. Many medications and methods are used for COVID-19 treatment. All national science committees are attempting to create standard treatment protocols. For intensive care treatment of COVID-19 patients, many factors require management, and clinicians' experience is guiding future processes. We believe that this study will create awareness about this topic and contribute to the creation of standard treatment algorithms and the provision of better and safer healthcare services for this patient group.
Highlights
Coronaviruses are single-chain, positive-polarity, enveloped ribonucleic acid (RNA) viruses
In December 2019, it was understood that the agent causing a pneumonia epidemic in Wuhan city in China was the newly-identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was defined as coronavirus disease 2019 (COVID-19)
In this study, we aimed to investigate the experience of clinicians who have been participating in treatments for COVID-19 patients within intensive care and their observations during the critical monitoring process for this patient group
Summary
Coronaviruses are single-chain, positive-polarity, enveloped ribonucleic acid (RNA) viruses Their surfaces have rod-like extensions.[1] In December 2019, it was understood that the agent causing a pneumonia epidemic in Wuhan city in China was the newly-identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was defined as coronavirus disease 2019 (COVID-19). Severe COVID-19 infection initially begins with flu-like complaints and is a situation that progresses to hypoxemic respiratory failure in 7-10 days. These critical patients require intensive care and this necessity is assessed by intensive care clinicians.[4]. DESIGN AND SETTING: The population for this descriptive study comprised clinicians working in a variety of healthcare organizations in Turkey who provide monitoring and treatment within the intensive care process for COVID-19 patients. We believe that this study will create awareness about this topic and contribute to the creation of standard treatment algorithms and the provision of better and safer healthcare services for this patient group
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
